z-logo
open-access-imgOpen Access
Letter by Ng et al Regarding Article, “Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial”
Author(s) -
ChiFai Ng,
Jeremy YuenChun Teoh,
Peter KaFung Chiu
Publication year - 2022
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.121.057407
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , randomized controlled trial , cancer , gynecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom